Clinical Rheumatology

, Volume 25, Issue 3, pp 341–346 | Cite as

Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome

Prevalence and clinical significance in 335 patients
  • Norma Nardi
  • Pilar Brito-Zerón
  • Manuel Ramos-CasalsEmail author
  • Sira Aguiló
  • Ricard Cervera
  • Miguel Ingelmo
  • Josep Font
Original Article


The aim of this study was to analyze the prevalence and clinical significance of circulating auto-antibodies against nuclear and non-nuclear antigens in a large cohort of Spanish patients with primary Sjögren's syndrome (SS). We studied 335 patients diagnosed with primary SS seen consecutively in our department since 1994 and tested for anti-nuclear antibodies (ANA), anti-Ro/SS-A, anti-La/SS-B, anti-Sm, anti-ribonucleoprotein (anti-RNP), anti-smooth muscle antibodies (anti-SMA), anti-parietal cell antibodies (anti-PCA), anti-liver–kidney microsome type-1 (anti-LKM-1) antibodies and anti-mitochondrial antibodies (AMA). ANA were detected in 278 (83%) patients. The association of positive ANA with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies reached statistical significance at a titre of ANA >1/80 (p<0.001), while the presence of anti-Sm and anti-RNP was associated with positive ANA at a titre ≥1/320 (p=0.037 for Sm and p=0.016 for RNP). ANA titres correlated with the number of positive antibodies against specific nuclear antigens (p<0.001) but not with the number of positive antibodies against non-nuclear antigens. We found positive anti-Ro/SS-A antibodies in 111 (33%) patients, anti-La/SS-B in 78 (23%), anti-RNP in 8 (2%) and anti-Sm in 4 (1%). Anti-SMA antibodies were detected in 208 (62%) patients, with no significant associations with clinical or analytical SS features, while anti-PCA antibodies were found in 90 (27%) patients and were associated with a higher prevalence of thyroiditis and liver involvement. AMA were detected in 28 (8%) patients, although only 14 presented clinical and/or analytical evidence of liver involvement. No patient presented anti-LKM antibodies. ANA play a central role in the immunological expression of primary SS, due to their frequency and close association with the underlying presence of one or more anti-ENA antibodies. Positivity for antibodies against non-nuclear antigens such as anti-PCA and AMA suggests an association with some organ-specific autoimmune diseases (thyroiditis and primary biliary cirrhosis), while the presence of anti-SMA, in spite of their high prevalence, has no clinical significance in primary SS.


Auto-antibodies Sjogren syndrome 



The authors wish to thank David Buss for his editorial assistance.


  1. 1.
    Daniels T, Fox PC (1992) Salivary and oral components of Sjögren's syndrome. Rheum Dis Clin North Am 18:571–589PubMedGoogle Scholar
  2. 2.
    Moutsopoulos HM (1994) Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 72:162–165CrossRefPubMedGoogle Scholar
  3. 3.
    Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81:270–280CrossRefGoogle Scholar
  4. 4.
    Ramos-Casals M, Font J, Garcia-Carrasco M et al (2002) Primary Sjogren syndrome: hematologic patterns of disease expression. Medicine (Baltimore) 81:281–292CrossRefGoogle Scholar
  5. 5.
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al (1993) Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 36:340–347PubMedCrossRefGoogle Scholar
  6. 6.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedGoogle Scholar
  7. 7.
    Garcia-Carrasco M, Ramos-Casals M, Font J, Vives J (2003) Interpretación de las pruebas inmunológicas en el síndrome de Sjögren. In: Ramos-Casals M, García-Carrasco M, Anaya JM, Coll J, Cervera R, Font J, Ingelmo M (eds) Síndrome de Sjögren. Ed. Masson, Barcelona, pp 445–466Google Scholar
  8. 8.
    Alarcón-Segovia D, Cardiel MH (1989) Comparison between three diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMedGoogle Scholar
  9. 9.
    Hollingsworth PN, Pummer SC, Dawkins RL (1996) Antinuclear Antibodies. In: Peter JB, Shoenfeld Y (eds) Antibodies. Elsevier, Amsterdam, pp 74–90Google Scholar
  10. 10.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRefGoogle Scholar
  11. 11.
    Adams BB, Mutasim DF (2000) The diagnostic value of anti-nuclear antibody testing. Int J Dermatol 39:887–891CrossRefPubMedGoogle Scholar
  12. 12.
    Asmussen K, Andersen V, Bendixen G et al (1996) A new model for classification of disease manifestations in primary Sjögren's syndrome. J Intern Med 239:475–482CrossRefPubMedGoogle Scholar
  13. 13.
    Wise CM, Woodruff RD (1993) Minor salivary gland biopsies in patients investigated for primary Sjögren's syndrome. A review of 187 patients. J Rheumatol 20:1515–1518PubMedGoogle Scholar
  14. 14.
    Shah F, Rapini RP, Arnett FC, Warner NB, Smith CA (1990) Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum 33:1682–1687PubMedCrossRefGoogle Scholar
  15. 15.
    Davidson BKS, Kelly CA, Griffiths ID (1999) Primary Sjögren's syndrome in the north east of England: a long-term follow-up study. Rheumatology 38:245–253PubMedCrossRefGoogle Scholar
  16. 16.
    Moutsopoulos HM, Zerva LV (1990) Anti-Ro (SS-A)/La (SS-B) antibodies and Sjogren's syndrome. Clin Rheumatol 9(Suppl 1):123–130CrossRefPubMedGoogle Scholar
  17. 17.
    Alexander EL, Arnett FC, Provost TT, Stevens MB (1983) Sjögren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities and serologic hyperreactivity. Ann Intern Med 98:155–159PubMedGoogle Scholar
  18. 18.
    Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjogren's syndrome. Medicine (Baltimore) 61:247–257Google Scholar
  19. 19.
    Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M et al (1986) Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 29:196–206PubMedCrossRefGoogle Scholar
  20. 20.
    Manoussakis MN, Tzioufas AG, Pange PJ, Moutsopoulos HM (1986) Serological profiles in subgroups of patients with Sjogren's syndrome. Scand J Rheumatol 61:89–92Google Scholar
  21. 21.
    Markusse HM, Veldhoven CH, Swaak AJ, Smeenk RT (1993) The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjögren's syndrome. Rheumatol Int 13:147–150CrossRefPubMedGoogle Scholar
  22. 22.
    Fox RI, Robinson C, Curd J, Michelson P, Bone R, Howell FV (1986) First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol 61 (Suppl):28–30Google Scholar
  23. 23.
    Wegelious O, Fyhrquist F, Adner PL (1970) Sjogren's syndrome associated with vitamin B12 deficiency. Acta Rheumatol Scand 16:184–190PubMedCrossRefGoogle Scholar
  24. 24.
    Williamson J, Paterson RW, McGavin DD, Greig WR, Whaley K (1970) Sjogren's syndrome in relation to pernicious anaemia and idiophatic Addison's disease. Br J Ophthalmol 54:31–36PubMedCrossRefGoogle Scholar
  25. 25.
    Pedro-Botet J, Coll J, Tomás S, Soriano JC, Gutiérrez Cebollado J (1993) Primary Sjogren's syndrome associated with chronic atrophic gastritis and pernicious anemia. J Clin Gastroenterol 16:146–148PubMedCrossRefGoogle Scholar
  26. 26.
    Talwalkar JA, Lindor KD (2003) Primary biliary cirrhosis. Lancet 362:53–61CrossRefPubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2005

Authors and Affiliations

  • Norma Nardi
    • 1
  • Pilar Brito-Zerón
    • 1
  • Manuel Ramos-Casals
    • 1
    • 2
    Email author
  • Sira Aguiló
    • 1
  • Ricard Cervera
    • 1
  • Miguel Ingelmo
    • 1
  • Josep Font
    • 1
  1. 1.Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of MedicineUniversity of BarcelonaBarcelonaSpain
  2. 2.Servei de Malalties Autoimmunes, Hospital ClínicBarcelonaSpain

Personalised recommendations